Rochelle Lear
Rochelle Lear publishes mostly in Genetics, Oncology and Biotechnology, on topics such as Virus-based gene therapy research, CAR-T cell therapy research and Cancer Research and Treatments.
- World rank
- #5,829,715 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #330,932 of 367,258
- Works
- 19
- Citations
- 102
- Citations per work
- 5.4
What does Rochelle Lear research?
Rochelle Lear's work is mostly in Biochemistry, Genetics and Molecular Biology (42%), Medicine (38%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences842.1%
- Health Sciences738.5%
- Medicine738.5%
- Everything else419.4%
- 1Genetics19% of their works
- 2Oncology18% of their works
- 3Biotechnology14% of their works
- 4Radiology, Nuclear Medicine and Imaging14% of their works
- 5Molecular Biology9% of their works
- 6Internal Medicine7% of their works
Research topics
- Virus-based gene therapy research
- CAR-T cell therapy research
- Cancer Research and Treatments
- Viral Infectious Diseases and Gene Expression in Insects
- Venous Thromboembolism Diagnosis and Management
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Orthopedic Infections and Treatments
Which keywords describe Rochelle Lear's research?
The keywords of their largest research topics: Gene Therapy, Immunotherapy, Tumor Regression, AAV, Viral Vectors, CAR T Cells, Chimeric Antigen Receptor and Bacterial Therapy.
- Therapeutic Antibodies
- Periprosthetic Joint Infection
- Venous Thromboembolism
- Radiopharmaceuticals
- Mammalian Cells
- Glycosylation
- Bacterial Therapy
- CAR T Cells
- AAV
- Immunotherapy
- Gene Therapy
- Tumor Regression
- Viral Vectors
- Chimeric Antigen Receptor
- Tumor Targeting
- Antithrombotic Therapy
- PET Imaging
- Recombinant Protein
- Fc Receptors
- Prosthetic Joint Infections
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Gene Therapy192 topics
- Immunotherapy182 topics
- Tumor Regression182 topics
- AAV111 topic
- Viral Vectors111 topic
- CAR T Cells101 topic
- Chimeric Antigen Receptor101 topic
- Bacterial Therapy81 topic
- Tumor Targeting81 topic
- Glycosylation72 topics
- Antithrombotic Therapy41 topic
- Mammalian Cells41 topic
- PET Imaging41 topic
- Radiopharmaceuticals41 topic
- Recombinant Protein41 topic
- Venous Thromboembolism41 topic
- Fc Receptors31 topic
- Periprosthetic Joint Infection31 topic
- Prosthetic Joint Infections31 topic
- Therapeutic Antibodies31 topic
Where does Rochelle Lear work?
Rochelle Lear's main affiliation in the publication record is PsiOxus Therapeutics (United Kingdom), United Kingdom.
How many publications and citations does Rochelle Lear have?
OpenAlex counts 19 works and 102 citations for Rochelle Lear, an h-index of 5, ranking #5,829,715 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rochelle Lear. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.